rs1553751726

Variant summary

Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM2PP3_Moderate

The NM_005051.3(QARS1):​c.1573C>T​(p.Arg525Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000958 in 1,461,868 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R525Q) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000096 ( 0 hom. )

Consequence

QARS1
NM_005051.3 missense

Scores

10
7
2

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 2.03

Publications

0 publications found
Variant links:
Genes affected
QARS1 (HGNC:9751): (glutaminyl-tRNA synthetase 1) Aminoacyl-tRNA synthetases catalyze the aminoacylation of tRNA by their cognate amino acid. Because of their central role in linking amino acids with nucleotide triplets contained in tRNAs, aminoacyl-tRNA synthetases are thought to be among the first proteins that appeared in evolution. In metazoans, 9 aminoacyl-tRNA synthetases specific for glutamine (gln), glutamic acid (glu), and 7 other amino acids are associated within a multienzyme complex. Although present in eukaryotes, glutaminyl-tRNA synthetase (QARS) is absent from many prokaryotes, mitochondria, and chloroplasts, in which Gln-tRNA(Gln) is formed by transamidation of the misacylated Glu-tRNA(Gln). Glutaminyl-tRNA synthetase belongs to the class-I aminoacyl-tRNA synthetase family. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2013]
QARS1 Gene-Disease associations (from GenCC):
  • diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, ClinGen, Orphanet
  • microcephaly-short stature-intellectual disability-facial dysmorphism syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.923

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
QARS1NM_005051.3 linkc.1573C>T p.Arg525Trp missense_variant Exon 17 of 24 ENST00000306125.12 NP_005042.1 P47897-1B7Z840
QARS1NM_001272073.2 linkc.1540C>T p.Arg514Trp missense_variant Exon 17 of 24 NP_001259002.1 P47897-2B7Z840
QARS1XM_017006965.3 linkc.1573C>T p.Arg525Trp missense_variant Exon 17 of 23 XP_016862454.2
QARS1NR_073590.2 linkn.1548C>T non_coding_transcript_exon_variant Exon 17 of 24

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
QARS1ENST00000306125.12 linkc.1573C>T p.Arg525Trp missense_variant Exon 17 of 24 1 NM_005051.3 ENSP00000307567.6 P47897-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000958
AC:
14
AN:
1461868
Hom.:
0
Cov.:
35
AF XY:
0.0000110
AC XY:
8
AN XY:
727234
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33480
American (AMR)
AF:
0.00
AC:
0
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000348
AC:
3
AN:
86254
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53418
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00000899
AC:
10
AN:
1111992
Other (OTH)
AF:
0.00
AC:
0
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Jun 16, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1573C>T (p.R525W) alteration is located in exon 17 (coding exon 17) of the QARS gene. This alteration results from a C to T substitution at nucleotide position 1573, causing the arginine (R) at amino acid position 525 to be replaced by a tryptophan (W). The amino acid is located in a functionally important protein domain:_x000D_ The p.R525W amino acid is located in the catalytic domain which is responsible for the ATP dependent attachment of the amino acid to the enzyme. It is located after the KMSKS motif which binds to ATP. Another missense substitution in the same loop (p.R515Y) was suggested to increase the aggregation of this protein and disrupt aminoacylation activity. However, there is no evidence protein aggregation and function would be affected by a change in position p.R525._x000D_ _x000D_ Structual modeling of this alteration is inconclusive_x000D_ Structural modeling performed in house at Ambry Genetics revealed that the position R525 is in a disordered loop lying in a buried region between the catalytic domain and the codon binding domain. This interfacial is identified to be subject to allosteric effects by (Zhang, 2014). The change R->W is unfavored (BLOSUM62 -3 and the nearby variant (R215W) has been identified to be pathogenic. However, R525W is not significantly destabilizing (-0.35) compared to R215W (10.52). While the variant likely perturbs in folding, structural evidence is not conclusive. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome Uncertain:1
May 18, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine with tryptophan at codon 525 of the QARS protein (p.Arg525Trp). The arginine residue is highly conserved and there is a moderate physicochemical difference between arginine and tryptophan. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with QARS-related conditions. ClinVar contains an entry for this variant (Variation ID: 520898). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C65"). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.85
BayesDel_addAF
Pathogenic
0.24
D
BayesDel_noAF
Uncertain
0.10
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.92
.;D;.;D
Eigen
Uncertain
0.36
Eigen_PC
Benign
0.15
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Pathogenic
1.0
D;D;D;D
M_CAP
Uncertain
0.14
D
MetaRNN
Pathogenic
0.92
D;D;D;D
MetaSVM
Uncertain
-0.037
T
MutationAssessor
Pathogenic
4.7
.;H;.;.
PhyloP100
2.0
PrimateAI
Pathogenic
0.90
D
PROVEAN
Pathogenic
-7.4
D;D;D;.
REVEL
Uncertain
0.61
Sift
Pathogenic
0.0
D;D;D;.
Sift4G
Pathogenic
0.0
D;D;D;D
Polyphen
1.0
.;D;.;.
Vest4
0.87, 0.83, 0.89
MutPred
0.78
.;Loss of methylation at R525 (P = 0.0396);.;.;
MVP
0.54
MPC
1.1
ClinPred
1.0
D
GERP RS
3.0
PromoterAI
0.019
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.93
gMVP
0.91
Mutation Taster
=57/43
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1553751726; hg19: chr3-49136818; COSMIC: COSV60275602; COSMIC: COSV60275602; API